Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05257343 · ClinicalTrials.gov registry record · NA
Efficacy of a Low Dose, Oral, Liquid Iron Supplement on Restoring Inadequate Blood Iron to Normal Levels
A NA study, sponsored by Applied Science & Performance Institute.
- Completed
- Registry status
- NA
- Development phase
- 95
- Enrollment target
NCT05257343 is a NA study that has completed, run by Applied Science & Performance Institute. The registered enrollment target is 95 participants.
The verdict
NCT05257343, a NA study, has completed, sponsored by Applied Science & Performance Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
Study Summary
This is a randomized, double-blind, placebo-controlled, 8-week intervention clinical study assessing the safety and efficacy of a new low-dose liquid iron supplement in restoring iron levels to normal ranges without promoting constipating side-effects among healthy premenopausal women with non-anemic iron deficiency. The primary outcomes will be an Iron Panel of Serum Iron, Ferritin, Total iron-binding capacity, Transferrin saturation, Complete Blood Count, and high sensitivity - C-Reactive Protein. Secondary outcomes will be surveys on gastrointestinal distress/discomfort and well-being. Adverse events will also be reported.
Interventions
- DIETARY_SUPPLEMENT Liquid Placebo Supplementation
- DIETARY_SUPPLEMENT Liquid Iron Supplement (Blood Builder ®)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2022-02-07 |
| Est. Completion | 2022-12-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05257343
The ClinicalTrials.gov registry entry for NCT05257343 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Applied Science & Performance Institute, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Liquid Placebo Supplementation is the first listed.
NCT05257343 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05257343 about?
NCT05257343 is a clinical study titled "Efficacy of a Low Dose, Oral, Liquid Iron Supplement on Restoring Inadequate Blood Iron to Normal Levels". This is a randomized, double-blind, placebo-controlled, 8-week intervention clinical study assessing the safety and efficacy of a new low-dose liquid iron supplement in restoring iron levels to normal ranges without promoting constipating side-effects among healthy premenopausal women with non-anemi...
What is the current status of trial NCT05257343?
This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2022-02-07. Estimated completion is 2022-12-09.
What interventions are being tested in trial NCT05257343?
The interventions under investigation include: Liquid Placebo Supplementation (DIETARY_SUPPLEMENT), Liquid Iron Supplement (Blood Builder ®) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05257343?
This trial is sponsored by Applied Science & Performance Institute, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.